560TiP A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations

Authors :: Harriet S. Walter
Victoria Coyle
J.S. de Bono
A. Hughes
William H. West
T. Knurowski
Nigel Brooks
Fay Ashby
Simon Pacey
Neil Anthony Pegg
Louise Carter
Simon J. Crabb
Alastair Greystoke
Ruth Plummer
Karen Clegg
Source :: Annals of Oncology. 32:S617
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Phase (matter)
medicine
In patient
Hematology
business

Tools